Reducing Health Care Costs

The Proposed Rule on Drug Rebates

The following statement is from NHC’s Chief Executive Officer, Marc Boutin, JD: Today’s announcement by Secretary Azar and Inspector General Levinson appears to be a great step toward putting patients […]

Read more

Recent NHC Comments Submitted to FDA & CMS

By Eric Gascho, NHC Vice President of Policy and Government Affairs The National Health Council frequently submits letters and comments on the administration’s rules and actions when its subjects are […]

Read more

The NHC’s Policymaking Process

By Eric Gascho, Vice President, Policy & Government Affairs The National Health Council (NHC) has a member-driven policy development process, which was just completed for 2019. Our patient advocate members […]

Read more

NHC Launches Drug Pricing Blueprint Tracker

Since its release, many of the high-level priorities in the Department of Health and Human Services’ American Patients First drug pricing blueprint have been developed into specific policies, either through […]

Read more

Two Wrongs Don’t Make a Right

By Marc Boutin, JD, NHC Chief Executive Officer Last week, the Centers for Medicare and Medicaid Services (CMS) issued a new policy touted as a way to cut drug spending […]

Read more